Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia
NCT03825744
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Aplastic Anemia
Interventions
DRUG:
Hetrombopag Olamine+Standard Therapy
DRUG:
Placebo+Standard Therapy
Sponsor
Jiangsu HengRui Medicine Co., Ltd.